Zobrazeno 1 - 10
of 103
pro vyhledávání: '"L. D. Kohn"'
Autor:
L. D. Kohn
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 82:3998-4009
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:1758-1767
To evaluate the extent and clinical relevance of epitope heterogeneity for stimulating TSH receptor antibodies (TSHRAbs), we measured the activity of IgG preparations from 66 untreated patients with Graves' disease using Chinese hamster ovary (CHO) c
Autor:
Guo-Guang Du, L. D. Kohn, A. Rentoumis, Peter Kopp, J L Jameson, Wen-Xia Gu, Laird D. Madison, Chris Albanese
Publikováno v:
Endocrinology. 136:3146-3153
The hyt/hyt mouse is hypothyroid because of a mutation in the TSH receptor (TSH-R). In this report, we confirm the presence of a Pro to Leu mutation in amino acid 556 of the fourth transmembrane domain (TM4) of the TSH-R. This Pro is highly conserved
Publikováno v:
The Journal of Immunology. 154:4830-4835
Experimental systemic lupus erythematosus (SLE) can be induced in mice by immunization with a human monoclonal anti-DNA Ab, bearing a major Id 16/6Id. Immunized mice initially produce Abs to 16/6Id, DNA and nuclear Ags, and subsequently develop vario
Publikováno v:
The Journal of Immunology. 153:873-880
Experimental SLE can be induced in mice by immunization with a human mAb to DNA (16/6Id). Immunized mice develop Abs to the 16/6Id immunogen, DNA, and nuclear Ags. Subsequently, clinical manifestations of disease develop, including leukopenia, protei
Publikováno v:
Journal of Biological Chemistry. 267:5977-5984
Monoclonal antibodies, D2 and 4G11, selected by the autoantiidiotypic approach following injection of thyrotropin (TSH) into mice, mimic TSH in binding to receptors on thyroid membranes. Based on TSH receptor transfection studies, D2 and 4G11 show un
Localization of gene encoding the thyroid stimulating hormone receptor (Tshr) on mouse Chromosome 12
Publikováno v:
Mammalian Genome. 7:626-628
Publikováno v:
Reviews in endocrinemetabolic disorders. 1(1-2)
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(6)
Blocking-type TSH-binding inhibitor Igs (TBIIs) are known to cause hypothyroidism and an atrophic thyroid gland in patients with primary myxedema. They can block the activity of thyroid-stimulating antibodies (TSAbs) in Graves' patients as well as th
Autor:
C, Giuliani, G, Napolitano, A, Mastino, S, Di Vincenzo, C, D'Agostini, S, Grelli, I, Bucci, D S, Singer, L D, Kohn, F, Monaco, E, Garaci, C, Favalli
Publikováno v:
European journal of immunology. 30(3)
In this study we examined the effect of the synthetic peptide thymosin-alpha1 (T(alpha)1) on MHC class I expression in FRTL-5 cells. Treatment with T(alpha)1 increased expression of MHC class I surface molecules and mRNA, which reached its peak (153